Approval · Notice of Compliance 9404 · 2008
APO-RANITIDINE: Notice of Compliance 9404
Issued February 22, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9404
- Date
- February 22, 2008
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation
- Therapeutic class
- Histamine H2-receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-RANITIDINE | Not yet assigned | — |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB